Global Hemostatic Dressing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Global Hemostatic Dressing Market Research Report 2023-Competitive Analysis, Status and Outlook by Type, Downstream Industry, and Geography, Forecast to 2029

Hemostatic dressings have the ability to promote blood clotting. Hemostatic dressings stop bleeding from abrasions, puncture wounds, or bleeding from veins or arteries. Hemostatic dressings are used in wound management in a variety of situations including surgery, emergency and trauma, military gunshot wounds, and more.

Market Overview:

The latest research study on the global Hemostatic Dressing market finds that the global Hemostatic Dressing market reached a value of USD 411.1 million in 2022. It’s expected that the market will achieve USD 733.87 million by 2028, exhibiting a CAGR of 10.14% during the forecast period.

Hospitals have a greater demand for hemostatic dressings

Blood plays a vital role in the human body. Bleeding is an important cause of casualties. The human body has its own hemostasis mechanism, the process is complicated and the ability is limited. In emergency situations such as hospitals, when the body's own hemostatic mechanisms cannot effectively stop the bleeding, hemostatic dressings are needed to save lives. Hemostatic dressings have the ability to promote blood coagulation and can be used in various operations to achieve a hemostatic effect. Therefore, hospitals have a large demand for hemostatic dressings.

Increasing adoption of hemostatic dressings in hospitals is one of the significant factors driving the growth of the market, where hospitals adopt hemostatic dressings for various procedures including plastic surgery, general surgery, cardiovascular surgery, and others. Overall, the high demand for hemostatic dressings in hospitals is driving the growth of the hemostatic dressings industry.

The demand for hemostatic dressings by the military is driving the industry

On the one hand, hemostatic dressings can be used to treat stab wounds, gunshot wounds, blast injuries, etc., and the use of first responders in the military can prevent blood loss and reduce the risk of death. Hemostatic dressings are one of the essential medicines in a personal first aid kit in the military.

On the other hand, due to the particularity of military occupations, the extremely harsh natural environment will inevitably become one of the working environments that soldiers must face. For example, plateaus, cold regions, hot regions, deserts, islands and other special environments. A variety of injuries can occur in a variety of harsh environments. Even in peacetime, training and disaster relief operations can still cause soldiers to experience various traumas in special environments. Therefore, hemostatic dressings are in great demand in the military.

There are certain barriers to entry

Hemostatic dressing as one of the important medical products, different countries have put forward certain requirements on the qualification certification, production and management of hemostatic dressing, resulting in certain barriers to entry in the industry.

At the same time, new high-end dressings will be the future industry technology development trend, and the research and development of high-end dressings and clinical trials need to invest a lot of manpower, material resources and financial resources, only the industry leading enterprises can use their own industrial operation ability and brand influence to obtain the required development of capital, high-end R&D talents and other scarce resources. Therefore, the market share of hemostatic dressing industry will gradually concentrate to the leading enterprises in the industry, and the industry concentration will be further improved. New entrants need a lot of research and development funds and related investment, and there are certain barriers to entry. For the hemostatic dressing industry, entry barriers restrict the development of the industry to a certain extent.

Intensifying market competition

At present, the macro environment in the global market is more complex, commodity prices, energy costs increase, improve the complexity of business operations. Due to the large market demand for hemostatic dressing products, there are more competitive enterprises in the hemostatic dressing industry, and the competition in this industry is relatively fierce. In addition, high-value medical consumables have the characteristics of long product life cycle, high gross profit level and high added value, attracting new competitors to enter the market. With the further expansion of the market, competition in the hemostatic dressing industry will intensify.

Region Overview:

In 2021, the share of the Hemostatic Dressing market in North America stood at 39.63%.

Company Overview:

Teleflex is one of the major players operating in the Hemostatic Dressing market, holding a share of 26.53% in 2022.

Teleflex is a global provider of medical technology designed to improve people's health and quality of life. Teleflex's diverse product portfolio provides solutions in the areas of vascular and interventional access, surgery, anesthesia, cardiac care, urology, emergency medicine and respiratory care.

Septodont is a French pharmaceutical and medical device company. Since its founding in 1932, Septodont has been at the forefront of the dental medicine field, developing, manufacturing and distributing a wide variety of high-quality dental products.

StatSeal products are developed and manufactured by Biolife, LLC, a privately held United States company headquartered in Sarasota, Florida. Biolife was founded in 1999 by Dr. Jim Reding, Charlie Entenmann, John Thompson and James Patterson.

Segmentation Overview:

Among different product types, Mucoadhesive Agents segment is anticipated to contribute the largest market share in 2027.

Mucoadhesive Agents

Mucoadhesives work by strongly adhering to damaged tissue and physically sealing bleeding wounds.

Factor Concentrators

The factor concentrator can quickly absorb the water in the blood and concentrate the cells and protein components in the blood, which will promote the formation of blood clots and thus play a hemostatic effect.

Precoagulants

Precoagulants are also a topical hemostatic agent. Coagulants act to stop bleeding by delivering high concentrations of procoagulant factors to bleeding wounds.

Others

There are other types, for example, hemostatic dressings made from proprietary algae-derived polymers

Application Overview:

The market's largest segment by application is the segment Hospital, with a market share of 50.96% in 2021.

Hospital

In hospitals, hemostatic dressings are used in a variety of surgical procedures, including cardiovascular surgery, general surgery, orthopedic surgery, and more.

Military

Hemostatic dressings can be used in the military; hemostatic dressings can be used for gunshot wounds, wound treatment in various situations.

Others

Hemostatic dressings can be used to deal with daily careless cuts, abrasions and other situations.

Key Companies in the global Hemostatic Dressing market covered in Chapter 3:

DermaRite
Milliken
CELOX
Hemostasis
BD
Omni-stat
Septodont
LifeScience PLUS
Deroyal
CuraMedical
Teleflex
Biolife
Convatec
Tricol Biomedical
Axio Biosolutions

In Chapter 4 and Chapter 14.2, on the basis of types, the Hemostatic Dressing market from 2018 to 2029 is primarily split into:

Mucoadhesive Agents
Factor Concentrators
Precoagulants
Others

In Chapter 5 and Chapter 14.3, on the basis of Downstream Industry, the Hemostatic Dressing market from 2018 to 2029 covers:

Hospital
Military
Others

Geographically, the detailed analysis of consumption, revenue, market share and growth rate, historic and forecast (2018-2029) of the following regions are covered in Chapter 8 to Chapter 14:

North America (United States, Canada)
Europe (Germany, UK, France, Italy, Spain, Russia, Netherlands, Turkey, Switzerland, Sweden)
Asia Pacific (China, Japan, South Korea, Australia, India, Indonesia, Philippines, Malaysia)
Latin America (Brazil, Mexico, Argentina)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa)